• Explore /
  • Poster
  • / A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer: LACOG 1018.

A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer: LACOG 1018.

Abstract Video & Slides Poster

Authors

null

Fernanda Bronzon Damian

Hospital São Lucas da PUCRS, Porto Alegre, Brazil; Hospital Fêmina - Grupo Hospitalar Conceição, Porto Alegre, Brazil; Brazilian Gynecologic Oncology Group (EVA), Brazil; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil

Fernanda Bronzon Damian , Andreia Cristina De Melo , Graziela Zibetti Dal Molin , Angelica Nogueira Rodrigues , Aknar Freire de Carvalho Calabrich , Gustavo Werutsky , Elias Abdo Filho , Taiane Francieli Rebelatto , Rafaela Gomes de Jesus , Mirela Foresti Jimenez

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT03936270

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5514)

DOI

10.1200/JCO.2023.41.16_suppl.5514

Abstract #

5514

Poster Bd #

209

Abstract Disclosures

Similar Posters

First Author: JUNG-YUN LEE

First Author: Theodore Willis Laetsch

First Author: Antonio Gonzalez Martin

First Author: Mansoor Raza Mirza